Global /France /Healthcare /Medical Devices /ALMKT

Mauna Kea Technologies S.A.

ALMKT

• EPA: ALMKT • Delayed

0.1838EUR -2.2%

0.2118 USD

As of 8 June 2026, Mauna Kea Technologies S.A. has a market cap of $20.55M USD, ranking #36846 globally and #435 in France. It ranks #3309 in the Healthcare sector, and #703 in the Medical Devices industry.

Global Rank

36846

Country Rank

435

Sector Rank

3309

Industry Rank

703

Key Stats

Market Cap

$20.55MUSD

17.84M EUR

Enterprise Value

$57.66MUSD

50.04M EUR

Revenue (TTM)

$10.27MUSD

8.91M EUR

EBITDA (TTM)

-$5.33MUSD

-4.62M EUR

Net Income (TTM)

$12.41MUSD

10.77M EUR

EBITDA Margin

-52%

Profit Margin

121%

PE Ratio

1.7

PS Ratio

2.0

Company Profile

Country (HQ)

France

Sector

Healthcare

Industry

Medical Devices

CEO

Alexandre Loiseau open_in_new

Employees

Founded

2000

Website

maunakeatech.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-2.2%	1.5%	16%	19%	98%	157%	132%	-66%	-87%

News

Markets

Exchange	Ticker	Price	Quotes
Euronext Paris (EPA) MIC: XPAR PRIMARY	ALMKT Mauna Kea Technologies SA Act. Categorie -O- ISIN: FR0010609263 Shares Out.: Shares Outstanding: 192.097M¹ Shares Float: 191.467M² TV: TradingView: EURONEXT: ALMKT SA: Stock Analysis: EPA: ALMKT YF: Yahoo Finance: ALMKT.PA GF: Google Finance: EPA: ALMKT BA: Barron's: ALMKT MS: Morningstar: XPAR: ALMKT	0.1838 EUR	TV: TradingView: EURONEXT: ALMKT SA: Stock Analysis: EPA: ALMKT YF: Yahoo Finance: ALMKT.PA GF: Google Finance: EPA: ALMKT BA: Barron's: ALMKT MS: Morningstar: XPAR: ALMKT
London Stock Exchange (LSE / LON) MIC: XLON	0P5I Mauna Kea Technologies SA Act. Categorie -O- ISIN: FR0010609263 TV: TradingView: LSE: 0P5I SA: Stock Analysis: LON: 0P5I YF: Yahoo Finance: 0P5I.L GF: Google Finance: LON: 0P5I BA: Barron's: 0P5I MS: Morningstar: XLON: 0P5I	0.1876 EUR	TV: TradingView: LSE: 0P5I SA: Stock Analysis: LON: 0P5I YF: Yahoo Finance: 0P5I.L GF: Google Finance: LON: 0P5I BA: Barron's: 0P5I MS: Morningstar: XLON: 0P5I

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Mauna Kea Technologies S.A.

Mauna Kea Technologies SA manufactures and sells medical devices in Europe and internationally. It offers a range of medical devices for gastroenterology, pulmonology, and urology applications. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform that enables unique in vivo cellular visualization, allowing doctors to monitor disease evolution over time, evaluate reactions as they occur, classify areas of uncertainty, guide surgical interventions, and help diagnose and treat patients. The company was incorporated in 2000 and is headquartered in Paris, France.

Similar Companies

Industry: Medical Devices (France)

Name	Market Cap (USD) diff.	PE	Country
EssilorLuxottica Société anonyme EPA: EL	$97.15B 84.32B EUR 473K%	36.7	France
Sartorius Stedim Biotech S.A. EPA: DIM	$17.58B 15.26B EUR 85K%	56.8	France
bioMérieux S.A. EPA: BIM	$9.49B 8.23B EUR 46K%	20.9	France
Eurobio Scientific Société anonyme EPA: ALERS	$266.8M 231.57M EUR 1K%	47.3	France
Carvolix S.A. EPA: AFME	$195.22M 169.44M EUR 850%	-	France
Guerbet S.A. EPA: GBT	$172.96M 150.12M EUR 742%	-	France

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 843K%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 782K%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 774K%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 616K%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 587K%	38.3	United States
Medtronic plc NYSE: MDT	$101.9B 496K%	22.2	Ireland

chevron_leftBack